-+ 0.00%
-+ 0.00%
-+ 0.00%

CONTEXT THERAPEUTICS - CTIM-76 PHASE 1A TRIAL ONGOING, INTERIM DATA EXPECTED JUNE 2026

Reuters·04/02/2026 11:30:00

Please log in to view news